Infantile myofibromatosis (IMF) is a benign tumor form characterized by the development of nonmetastatic tumors in skin, bone, muscle and sometimes viscera. Autosomal-dominant forms of IMF are caused by mutations in the PDGFRB gene, but a family carrying a L1519P mutation in the NOTCH3 gene has also recently been identified. In this study, we address the molecular consequences of the NOTCH3L1519P mutation and the relationship between Notch and PDGFRB signaling in IMF. The NOTCH3L1519P receptor generates enhanced downstream signaling in a ligand-independent manner. Despite the enhanced signaling, the NOTCH3L1519P receptor is absent from the cell surface and instead accumulates in the endoplasmic reticulum. Furthermore, the localization of the NOTCH3L1519P receptor in the bipartite, heterodimeric state is altered, combined with avid secretion of the mutated extracellular domain from the cell. Chloroquine treatment strongly reduces the amount of secreted NOTCH3L1519P extracellular domain and decreases signaling. Finally, NOTCH3L1519P upregulates PDGFRB expression in fibroblasts, supporting a functional link between Notch and PDGF dysregulation in IMF. Collectively, our data define a NOTCH3–PDGFRB axis in IMF, in which an IMF-mutated NOTCH3 receptor elevates PDGFRB expression. The functional characterization of a ligand-independent gain-of-function NOTCH3 mutation is important for Notch therapy considerations for IMF, including strategies aimed at altering lysosome function.
29 October 2025 in Archives of Gynecology and Obstetrics
Placenta accreta spectrum (PAS) is a serious obstetric complication, characterized by the placenta accreta and increta to the uterine wall, which fails to detach spontaneously from the uterine following childbirth, potentially resulting in severe hemorrhage and additional complications. The incidence of PAS is increasing in the world, which is mainly attributed to a global escalation in cesarean section rates, underscoring the critical need to elucidate its molecular pathogenesis and to devise efficacious clinical interventions. Recent studies have identified novel molecular mechanisms that have significantly enhanced our comprehension of disease pathophysiology and informed predictive and therapeutic strategies. Here, we review the principal molecular pathogenesis of PAS, explore the potential translation of these findings into clinical applications, and assess the impact of emerging technologies on advancing research in this domain.